Syntrix's dual CXCR1/CXCR2 inhibitor for combos in oral, lung cancers

DISEASE CATEGORY: Cancer

INDICATION: Lung cancer; solid tumors

Mouse studies suggest combining the dual CXCR1/CXCR2 inhibitor SX-682 with anti-PD-1

Read the full 179 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE